Skip to main content
War in Gaza:: find out how we're responding
Learn more
446 Results For "antiretroviral treatment"
 
The Stop Stocks Outs Project South Africa April 2015
HIV/AIDS

HIV: Antiretroviral drugs fail to consistently reach patients in countries most affected by HIV/AIDS

This report is a first of its kind, looking at the availability of ARVs at patient level. Whilst shortages due to international suppliers’ inability to meet demand are acknowledged, lack of drug availability in local clinics, stemming from failure to ensure “last mile” delivery is not monitored and therefore woefully ignored. Report - 30 Nov 2015
 
HIV SUPPORT GROUP COMMUNITY  MAPUTO MOZAMBIQUE
Access to medicines

Stockouts: Testimonies from patients and medical staff

Testimonies from AIDS patients. “Once I was two weeks without my ARVs. When I arrived at the health centre I was told there was no nurse there and no one found an alternative solution for me, so I went back home empty handed and desperate, " Sanculani Langui, from Marara Centro, Tete province, Mozambique. Voices from the Field - 30 Nov 2015
 
HIV program in Ndhiwa sub-county, Homa Bay
HIV/AIDS

Despite better access to treatment, many AIDS patients in African hospitals still die

A new MSF study shows that 50% of AIDS inpatients in Homa Bay hospital, Kenya, are failing their treatment. Press Release - 27 Nov 2015
 
msf-placeholder
South Africa

Chose life – chose treatment

The fact is that nobody should be dying of AIDS today, nobody should even be infecting others: as long as you are on dutiful, daily and lifelong treatment, you have close to zero risk of passing on the virus to your partner or unborn child.

So why is it that AIDS is still killing 140,000 South Africans every year, and infecting three times this number - the equivalent of the entire population of Khayelitsha?
Project Update - 26 Nov 2015
 
Swaziland - Figthing HIV and TB dual epidemic
HIV/AIDS

Countries should take up new WHO ‘test and treat’ guidelines

MSF welcomes progress on getting HIV treatment to more people and urges all affected countries to take up new World Health Organization (WHO) ‘test and treat’ guidelines before next June’s UN High-level Meeting on HIV/AIDS, where donor governments should commit to a funding plan to close the global treatment gaps. Press Release - 24 Nov 2015
 
Sana’a. Yemen
Yemen

Antiretroviral treatment beneath the bombs

More than 1,300 people living with HIV/AIDS are receiving antiretroviral treatment in Yemen, around half of them in Sana’a, the capital. Dr Abdulfattah Al-Alimi, Field coordinator and medical team leader of MSF's HIV/AIDS project in Yemen, discuss how the current war is affecting the patients' treatment. "In the end, this is our job and responsibility: to find a way so no one has to interrupt their treatment because of the war," says Dr Abdulfattah Al-Alimi. " These are difficult times for my country, but we are trying to prevent them from being even more so for people living with the virus." Voices from the Field - 29 Oct 2015
 
msf-placeholder
HIV/AIDS

MSF applauds World Health Organization move toward treatment for everyone with HIV

“It’s no longer only a question of when to start people on treatment, but also how to help people stay on treatment for life and to maintain ‘undetectable’ levels of virus in their blood," says said Dr Marc Biot, MSF’s operational coordinator for HIV. " We need to make sure HIV treatment fits into people’s lives better, just like with any other chronic disease in industrialized countries.” Press Release - 30 Sep 2015
 
msf-placeholder
Kenya

Moving from MDGs to SDGs: Transforming aspirations for better health into reality works.

"In order to stand a better chance to achieve the SDG targets by 2030, domestic resources for health financing need to substantially increase while policies need to be formulated based on realistic assessments of obstacles that people face in getting access to health care." Opinion - 25 Sep 2015
 
msf-placeholder
HIV/AIDS

As HIV burden overwhelmingly shifts to ‘middle-income’ countries, access to affordable medicines is under threat

“If these policies are allowed to continue, middle-income countries face nothing short of a calamity that poses a major threat to the global HIV response and other health initiatives” says Leena Menghaney, head of MSF’s Access Campaign in South Asia. MSF warns that middle-income countries (MICs), which will be home to 70% of people living with HIV by 2020, face increasing threats to their ability to access affordable generic medicines. Press Release - 22 Jul 2015
 
msf-placeholder
HIV/AIDS

MSF warns successful global HIV response will require bigger emphasis on adherence

Not enough is being done to ensure people on antiretroviral treatment (ART) reach and maintain ‘undetectable’ levels of virus in their blood. “Our experience to date on one hand is positive, with people who adhere to treatment living longer and healthier lives, but on the other hand, we see major gaps in the continuum of care that painfully illustrate the shortcomings of the HIV response,” said Dr. Helen Bygrave, HIV Medical Advisor for MSF’s South Africa Medical Unit. Press Release - 21 Jul 2015
Cholera intervention in South Kivu
Médecins Sans Frontières (MSF)

Independent medical humanitarian assistance

We provide medical assistance to people affected by conflict, epidemics, disasters, or exclusion from healthcare. Our teams are made up of tens of thousands of health professionals, logistic and administrative staff - most of them hired locally. Our actions are guided by medical ethics and the principles of independence and impartiality. We are a non-profit, self-governed, member-based organisation.

Learn more